Biocartis Group N.V.
BIOGFOTCHealthcare
$0.66
$-3.84(-85.33%)
Market Cap$65406204
P/E Ratio—
52W High$0.66
52W Low$0.66
Biocartis Group N.V. (BIOGF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOGF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $57.48M | $48.27M | $43.13M | $37.44M |
| Cost of Revenue | $29.80M | $33.92M | $26.28M | $21.33M |
| Gross Profit | $27.68M | $14.35M | $16.84M | $16.12M |
| Gross Margin %(computed) | 48.16% | 29.72% | 39.06% | 43.04% |
| Operating Expenses | ||||
| R&D Expenses | $38.39M | $48.05M | $40.93M | $39.84M |
| G&A Expenses | $3.52M | $3.32M | $3.16M | $5.25M |
| Total Operating Expenses | $74.43M | $76.64M | $63.23M | $71.46M |
| Operating Income | ($47.05M) | ($62.65M) | ($46.86M) | ($55.60M) |
| Operating Margin %(computed) | -81.85% | -129.78% | -108.66% | -148.49% |
| Interest Income | $0.00M | $1.08M | $0.00M | $0.00M |
| Interest Expense | $11.19M | $9.32M | $10.18M | $7.10M |
| Income Before Tax | ($65.62M) | ($71.72M) | ($63.16M) | ($64.17M) |
| Income Tax Expense | ($0.24M) | ($0.24M) | ($0.23M) | ($0.10M) |
| Net Income | ($65.38M) | ($71.47M) | ($62.93M) | ($64.07M) |
| Net Margin %(computed) | -113.74% | -148.07% | -145.92% | -171.10% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-1.08 | $-1.24 | $-1.11 | $-1.14 |
| Wtd Avg Shares | 60.55M | 57.55M | 56.61M | 56.07M |
| EBITDA | ($43.95M) | ($52.55M) | ($43.23M) | ($47.35M) |
| EBITDA Margin %(computed) | -76.47% | -108.87% | -100.24% | -126.45% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · M
Explore more Biocartis Group N.V. data
About Biocartis Group N.V. (BIOGF) Income Statement
Biocartis Group N.V. (BIOGF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, BIOGF reported revenue of $0.06B, gross profit of $0.03B (gross margin 48.16%), and net income of ($0.07B) — a net profit margin of -113.74%.
Frequently asked questions
BIOGF · 4 questionsBiocartis Group N.V. (BIOGF) reported revenue of $0.06B for 2022, up 19.1% year-over-year.
BIOGF revenueBIOGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09